Back to Journals » Journal of Pain Research » Tapentadol for moderate to severe acute pain in children and adolescents
Journal of Pain Research
- View all (2403)
- Volume 15, 2022 (160)
- Volume 14, 2021 (357)
- Volume 13, 2020 (359)
- Volume 12, 2019 (330)
- Volume 11, 2018 (336)
- Volume 10, 2017 (309)
- Volume 9, 2016 (140)
- Volume 8, 2015 (93)
- Volume 7, 2014 (76)
- Volume 6, 2013 (88)
- Volume 5, 2012 (63)
- Volume 4, 2011 (44)
- Volume 3, 2010 (26)
- Volume 2, 2009 (15)
- Volume 1, 2008 (7)
Journal Articles:
- Methylnaltrexone for Opioid-Induced Constipation (1)
- Tapentadol for moderate to severe acute pain in children and adolescents (10)
- Inhaled methoxyflurane for the treatment of acute trauma pain (4)
- Tapentadol: just another opioid or an innovative strong analgesic? (8)
- From acute to chronic pain: bench to bedside findings from consortium of SIMPAR young researchers (4)
- Oral Methylnaltrexone in the treatment of patients with opioid-induced constipation and noncancer pain (2)

Analgesic Drug Development for Children: A History of Shortcomings … Until Now
Dinh A, Berger A, Krane E
Journal of Pain Research 2021, 14:867-870
Published Date: 31 March 2021

Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
Eissa A, Tarau E, Beuter C, Radic T, Watson E, Sohns M, Lefeber C, Hammer GB
Journal of Pain Research 2021, 14:229-248
Published Date: 29 January 2021

Outcomes of the Pediatric Development Plan of Tapentadol
Eerdekens M, Radic T, Sohns M, Khalil F, Bulawa B, Elling C
Journal of Pain Research 2021, 14:249-261
Published Date: 29 January 2021


The challenge of developing pain medications for children: therapeutic needs and future perspectives
Eerdekens M, Beuter C, Lefeber C, van den Anker J
Journal of Pain Research 2019, 12:1649-1664
Published Date: 23 May 2019

Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients
Muse D, Tarau E, Lefeber C, Sohns M, Brett M, Goldberg J, Rosenburg R
Journal of Pain Research 2019, 12:1777-1790
Published Date: 31 May 2019

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18
Finkel JC, Goldberg J, Rosenburg R, Ariyawansa J, Sun T, Ochs-Ross R, Zannikos P, Zhang L, Etropolski M
Journal of Pain Research 2019, 12:1925-1936
Published Date: 28 June 2019


Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population
Watson E, Khandelwal A, Freijer J, van den Anker J, Lefeber C, Eerdekens M
Journal of Pain Research 2019, 12:2835-2850
Published Date: 14 October 2019

Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial
Beuter C, Volkers G, Radic T, Goldberg J, van den Anker J
Journal of Pain Research 2019, 12:3099-3112
Published Date: 13 November 2019

Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old
Khalil F, Choi SL, Watson E, Tzschentke TM, Lefeber C, Eerdekens M, Freijer J
Journal of Pain Research 2020, 13:3107-3123
Published Date: 24 November 2020


Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
Howard RF, Radic T, Sohns M, Eerdekens M, Waßmuth A
Journal of Pain Research 2020, 13:3157-3170
Published Date: 30 November 2020